James Andrew Huntington

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Janssen Pharmaceuticals, Inc., University of Cambridge. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Andrew Huntington. Retrieved from https://idiyas.com/inventor/james-andrew-huntington

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 40.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 26(Granted Patents)

Company Filing History:

8 out of 161

Janssen Pharmaceuticals, Inc.

patents

2 out of 439

University of Cambridge

patents

Years Active: 2016-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11155637 - Thrombin-binding antibody molecules and uses thereof (2021-10-26),

2. 10370454 - Thrombin-binding antibody molecules and uses thereof (2019-08-06),

3. 10351619 - Modified serpins for the treatment of bleeding disorders (2019-07-16),

4. 10287363 - Thrombin-binding antibody molecules and uses thereof (2019-05-14),

5. 9988463 - Thrombin-binding antibody molecules and uses thereof (2018-06-05),

6. 9988461 - Thrombin-binding antibody molecules and uses thereof (2018-06-05),

7. 9982035 - Modified serpins for the treatment of bleeding disorders (2018-05-29),

8. 9605082 - Thrombin-binding antibody molecules and uses thereof (2017-03-28),

9. 9518129 - Thrombin-binding antibody molecules and uses thereof (2016-12-13),

10. 9518128 - Thrombin-binding antibody molecules (2016-12-13),

Title: Innovations of James Andrew Huntington

Introduction

James Andrew Huntington is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biomedical research, particularly in the development of antibody molecules. With a total of 10 patents to his name, Huntington's work has the potential to impact medical treatments significantly.

Latest Patents

One of his latest patents is focused on thrombin-binding antibody molecules and their uses. This invention relates to isolated antibodies that recognize the exosite 1 epitope of thrombin and selectively inhibit thrombin without promoting bleeding. These antibody molecules may be useful in the treatment and prevention of thrombosis, embolism, and other conditions mediated by thrombin.

Career Highlights

Throughout his career, Huntington has worked with prominent organizations such as Janssen Pharmaceuticals, Inc. and Cambridge Enterprise Limited. His experience in these companies has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Huntington has collaborated with esteemed colleagues, including Trevor Baglin and Jonathan Langdown. These partnerships have fostered a collaborative environment that enhances the research and development of new medical technologies.

Conclusion

James Andrew Huntington's contributions to the field of biomedical research through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.